Sign In
Buy CVS
$98.32
-0.84 (-0.85%)
At Close: Jun 18, 2026
UnitedHealth, CVS Among Major Insurers To Fast-Track Prior Authorizations: Will It Cut Profits Even More?
12:07pm, Monday, 23'rd Jun 2025
Leading health insurers announced on Monday that they have agreed to a set of measures aimed at connecting patients to care faster and reducing paperwork for providers.
Why CVS Health (CVS) is a Top Value Stock for the Long-Term
10:46am, Monday, 23'rd Jun 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Aetna Supports Industry Actions to Simplify Prior Authorization
05:01am, Monday, 23'rd Jun 2025
Company commits to distinctive actions that will make it easier to navigate the health care system, access care, and achieve better health HARTFORD, Conn. , June 23, 2025 /PRNewswire/ -- Aetna, a CVS
New June Fortune 500 Industry Leaders Show 3 Ideal "Safer" Dividend Buys
05:12pm, Friday, 20'th Jun 2025
Three Fortune 500 Industry Leaders—Energy Transfer, Verizon, and World Kinect—currently meet the 'dogcatcher' ideal of fair price and safer dividends. Analyst targets project 21% to 50% net gains
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know
10:01am, Thursday, 19'th Jun 2025
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Two Healthcare Heavyweights, One Winner: UnitedHealth or CVS Health?
10:41am, Wednesday, 18'th Jun 2025
CVS gains steam as rising margins, strong Medicare results, and cost cuts set it apart from UNH.
Exploring CVS' Health Services Segment: A Key Growth Engine for 2025?
09:11am, Wednesday, 18'th Jun 2025
CVS' Health Services segment posts $43B in revenues as specialty pharmacy and Caremark deals drive 2025 growth prospects.
CVS Surges on Regulatory Relief, Medicare Advantage Push: Time to Buy?
04:00pm, Tuesday, 17'th Jun 2025
CVS surges 53.7% YTD as regulatory relief, strong execution and Medicare Advantage momentum fuel investor confidence.
5 Low Price-to-Book Value Stocks That You Can Buy in June
10:05am, Tuesday, 17'th Jun 2025
The P/B ratio helps to identify low-priced stocks with high growth prospects. USNA, CVS, PFE, STNE and PSFE are some such stocks.
3 Medical Services Stocks Capitalizing on the Healthcare AI Boom
12:11pm, Monday, 16'th Jun 2025
CVS, BTSG and WGS are three medical services stocks tapping into AI and tech-driven care to boost diagnostics, cut costs and drive growth in 2025.
4 Value Stocks to Shield Your Portfolio Amid Geopolitical Turmoil
10:31am, Monday, 16'th Jun 2025
As geopolitical risks jolt markets, STNE, CNC, CVS and PFE shine with low cash flow valuations and solid earnings outlooks.
4 Attractive GARP Picks for Your Portfolio Based on PEG Ratio
04:01pm, Thursday, 12'th Jun 2025
Here are four discounted PEG stocks that qualify our screening criteria and could be good picks. These are FLEX, CVS, URBN and EXEL.
CVS Health's MBR Improves: Can It Sustain Amid Elevated Cost Trends?
09:06am, Thursday, 12'th Jun 2025
CVS posts its first favorable MBR in quarters, but elevated cost trends test its ability to sustain the gains.
CVS vs. DHR: Which Stock Should Value Investors Buy Now?
12:40pm, Wednesday, 11'th Jun 2025
Investors with an interest in Medical Services stocks have likely encountered both CVS Health (CVS) and Danaher (DHR). But which of these two stocks is more attractive to value investors?
5 Ideal 'Safe' Buys From June Fortune Return On Leadership Screen
12:47pm, Tuesday, 10'th Jun 2025
Coincident to the June 5, 2025 annual launch of their Fortune 500, Fortune also partnered with Indiggo to measure Return On Leadership, called the ROL100. Arnold research focused on those 100 using Y
